Given all the challenges of dealing with payers, many clinical laboratories find themselves tempted by the idea of offering cash-based business lines such as direct-to-consumer (DTC) testing. The patient pays up front and undergoes the test, and the lab banks the income without the hassles of filing a claim and awaiting reimbursement. But labs should […]
To access this post, you must purchase The Dark Report.